Chargement en cours...
Advances in limb salvage treatment of osteosarcoma
Osteosarcoma is the most common primary malignant bone tumor; its standard treatment includes neoadjuvant chemotherapy combined with surgery. Neoadjuvant chemotherapy has significantly improved the 5-year survival and limb salvage rates in osteosarcoma since the 1870s. The survival rate of patients...
Enregistré dans:
| Publié dans: | J Bone Oncol |
|---|---|
| Auteurs principaux: | , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Elsevier
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5739147/ https://ncbi.nlm.nih.gov/pubmed/29296558 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jbo.2017.11.005 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|